-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
February 01, 2014 - Effectiveness
Reviews, the program supports
systematic appraisals of existing
scientific evidence regarding
treatments … experimental and epidemiologic studies,4,5
therapeutic strategies to decrease risk
have focused on … importance of patient-centered clinical
outcomes for evaluating the effectiveness of
lipid-modifying therapies … While our findings may suggest that one
therapeutic option provides a benefit over another, we
cannot … previous reviews on dietary modification and
reduction of lipids and CVD risk, we did not include
these therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
January 01, 2010 - diabetes in the
United States.
3,4
Thus, a large segment of the population requires glucose-lowering therapies … insulin
delivery and glucose monitoring for various populations of individuals with diabetes so that
therapeutic … of individuals with diabetes who are
receiving treatment in a usual care setting. … Intensive diabetes treatment and cardiovascular disease in
patients with type 1 diabetes. … Continuous glucose monitoring and intensive treatment of type
1 diabetes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
February 01, 2012 - Effectiveness
Reviews, the program supports
systematic appraisals of existing
scientific evidence regarding
treatments … Treatment,
therapy, or
intervention
-HSCT
Intermediate Outcomes
• Recurrence-free survival
• … Treatment,
therapy, or
intervention
-HSCT
Intermediate Outcomes
Slowing of the progression of or … Treatment,
therapy, or
intervention
-HSCT
Intermediate Outcomes
• Stable source of endogenous … selection to the past 15 years to ensure that we identified
evidence that is comparable in terms of therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
September 13, 2011 - may be extended up to 48 weeks for
patients with HCV genotype 1.5,6 The effects of antiviral therapies … may change with
the introduction of the new drug class.13,14
Adherence to treatments has been shown … treatment outcomes specifically in HCV antiviral therapy or
whether treatment adherence interventions … training), increasing the convenience of medication
use (e.g., simplifying drug dosing, tailoring the treatments … • Treatment regimens: prescribed antiviral therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
May 29, 2013 - It would also be of benefit to define some of the
therapies, such as exercise therapy. … The authors may consider adding a heading of
"Treatments" as opposed to a new heading of Medical
therapy … This review reflects the current state of therapeutic
options that have been tested comparatively in … For an unbiased
approach, it is the responsibility of the authors to
document that each of the therapeutic … The review for antiplatelet
therapy and methods of treatment for intermittent
claudication well review
-
effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - It is
not known whether these
therapies are better or worse than
other treatments for localized
prostate … [ti] OR therapies[ti] OR treatment*[ti] OR
treating[ti] OR treat[ti] OR therapy/mh
AND
Limits … or
received no initial
treatment
Clinical and
biochemical out-
comes of radiation
therapies for … It is not known
whether these therapies are better or worse
than other treatments for localized prostate … The absolute risk of
impotence and treatment-related morbidity
appeared to be similar to other treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - It is
not known whether these
therapies are better or worse than
other treatments for localized
prostate … [ti] OR therapies[ti] OR treatment*[ti] OR
treating[ti] OR treat[ti] OR therapy/mh
AND
Limits … or
received no initial
treatment
Clinical and
biochemical out-
comes of radiation
therapies for … It is not known
whether these therapies are better or worse
than other treatments for localized prostate … The absolute risk of
impotence and treatment-related morbidity
appeared to be similar to other treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
April 16, 2020 - chronic
pain patients and if they are, they are limited by Medicare to the point they
would not be therapeutic … majority of patients have been FORCED to reduce their stable,
effective pain medications to a non therapeutic … - Introduction to the American Massage Therapy Association … We note that the type, dosage, and duration of any
pain treatment, including opioid therapy, is best … from opioid therapy if safe prescribing practices are not followed.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-230-prostate-cancer-comments.pdf
September 17, 2020 - Disposition of Comments: CER 230 Therapies for Clinically Localized Prostate Cancer
Comparative … Effectiveness Review Disposition of Comments Report
Title: Therapies for Clinically Localized … Therapies for Clinically Localized Prostate Cancer.
Comparative Effectiveness Review No. 230. … Source: https://effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/report
Published Online … https://effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/report
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
January 01, 2009 - Completion Date: 1-12-10
1
Results of Topic Selection Process & Next Steps
Pharmacologic therapy … versus medical foods and nondietary approaches for the treatment of
phenylketonuria (PKU) will go forward … They are also interested in the
comparative cost effectiveness of these treatments. … Pharmacologic Therapy versus Medical Foods
for the Treatment of Phenylketonuria (PKU)
Nomination … Historically, the treatment of PKU has relied on nonpharmacologic therapies, with affected individuals
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
June 24, 2014 - management
era (i.e., since JNC-5 in 1993), what is the evidence on the effects of aggressive
medical therapy … (i.e., antihypertensive, antiplatelet, and antilipid treatment)
compared to renal artery angioplasty … What adverse events and complications have been associated with
aggressive medical therapy or renal … What treatment variables are associated with improved or worse outcomes of renal
artery angioplasty … designed to test whether renal-artery stenting, when added to protocol-
driven contemporary medical therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-disposition-comments.pdf
July 31, 2024 - Psychodynamic
therapies were not excluded
from this review. … have added a paragraph to
the discussion highlighting the
need for future research
assessing the therapeutic … components and combination of
therapeutic components that are
likely to be the most effective
across … compared with treatment as
usual. … compared with treatment as
usual.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
April 03, 2013 - therapies. … Second, not all of these treatments are cognitive-behavioral therapy. … because they can influence treatment adherence and
therapeutic response. "
This is a very key statement—good … as CBT-mixed; her treatment is one of the purest cognitive therapies around. … such as Present-Centered Therapy or treatment as usual as a control.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - (Low)
KQ2:
For
patients
with
RA,
do
drug
therapies
differ
in
their
… (Low)
KQ3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence, … RA in subgroups of patients based on stage of disease, prior therapy,
demographics, concomitant therapies … : a multiple-treatment Bayesian
metaanalysis. … based on stage of disease, prior therapy, demographics,
concomitant therapies, or comorbidities?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - (Low)
KQ2:
For
patients
with
RA,
do
drug
therapies
differ
in
their
… (Low)
KQ3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence, … RA in subgroups of patients based on stage of disease, prior therapy,
demographics, concomitant therapies … : a multiple-treatment Bayesian
metaanalysis. … based on stage of disease, prior therapy, demographics,
concomitant therapies, or comorbidities?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_consumer.pdf
May 01, 2011 - They may ask you to rate your pain so that they
can see if treatment is helping. … The amount of pain and type of pain from a broken hip can change
during your treatment. … These other
treatments include:
� Nerve blocks.
� Traction.
� Acupressure. … These therapies can be used before or after
an operation.
What is acupressure? … What is muscle-relaxation therapy?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
January 01, 2013 - treatments. … Treatment in Adolescents
Two trials evaluated therapies in children and
adolescents; one trial of … A
systematic review of treatments for refractory
depression in older people. … treatments. … Treatment in Adolescents
Two trials evaluated therapies in children
and adolescents; one trial of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
November 01, 2024 - Treatment for CKD stage 5 patients is dialysis or
kidney replacement therapy. … ;
16 years
Treatment:
Root canal
therapy
Control: no
treatment
% patients with event (age, … for periodontitis
or root canal treatments. … 16 years
Treatment:
Root canal
therapy
Control: no
treatment
% patients with event … 16 years
Treatment:
Root canal
therapy
Control: no
treatment
% patients with event (age
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-evidence-summary-updated-1.pdf
October 01, 2021 - • Timing of IBR and AR in Relation to Chemotherapy and Radiation Therapy
o Conducting IBR either … In the Results section of this Evidence Summary, we provide
numeric estimates of summary treatment effects … We found no evidence addressing timing of AR in relation to
radiation therapy. … When subgroup data
were reported, statistical analyses evaluating heterogeneity of treatment effects … Complications delaying other cancer
treatments
nd nd nd nd nd nd
Thromboembolic events ◆◆ DVT or
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
January 01, 2024 - For warfarin as treatment in the context of atrial fibrillation, in a 2022
systematic review developed … See
https://www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/diagnosis-
treatment/treatments … https://www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/diagnosis-treatment/treatments/btpills … treatments/btpills/btpills.pdf
27 Making Healthcare Safer IV – Anticoagulant Use
4. … with treatment
received.”